1. Home
  2. EZPW vs COLL Comparison

EZPW vs COLL Comparison

Compare EZPW & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

HOLD

Current Price

$25.43

Market Cap

1.6B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$45.17

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZPW
COLL
Founded
1989
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
EZPW
COLL
Price
$25.43
$45.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$24.00
$51.17
AVG Volume (30 Days)
1.1M
287.6K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.09
N/A
EPS
0.55
1.28
Revenue
$747,954,000.00
$631,449,000.00
Revenue This Year
$23.29
$26.20
Revenue Next Year
$10.88
$3.54
P/E Ratio
$45.64
$34.95
Revenue Growth
2.39
N/A
52 Week Low
$12.89
$23.23
52 Week High
$26.35
$50.79

Technical Indicators

Market Signals
Indicator
EZPW
COLL
Relative Strength Index (RSI) 66.78 44.64
Support Level $20.65 $43.81
Resistance Level $26.35 $48.74
Average True Range (ATR) 0.92 1.30
MACD 0.04 -0.13
Stochastic Oscillator 72.09 21.80

Price Performance

Historical Comparison
EZPW
COLL

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: